The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 18, 2023

Filed:

Sep. 09, 2019
Applicant:

Universität Basel, Basel, CH;

Inventors:

Gennaro De Libero, Bottmingen, CH;

Marco Lepore, Abingdon, GB;

Lucia Mori, Bottmingen, CH;

Assignee:

UNIVERSITÄT BASEL, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/725 (2006.01); C12N 5/0783 (2010.01); G01N 1/30 (2006.01); G01N 33/569 (2006.01); C12N 5/09 (2010.01); C12N 15/85 (2006.01); A61K 35/17 (2015.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/7051 (2013.01); A61K 35/17 (2013.01); A61P 35/00 (2018.01); C12N 5/0636 (2013.01); C12N 5/0693 (2013.01); C12N 15/85 (2013.01); G01N 1/30 (2013.01); G01N 33/56966 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/2307 (2013.01); C12N 2501/2315 (2013.01); C12N 2502/1114 (2013.01); C12N 2502/30 (2013.01);
Abstract

The invention relates to a method of isolating a T cell that expresses a T cell receptor capable of binding specifically to an antigen presented by a cancer cell in association with an MR1 molecule. The method comprises the steps of (a) providing a preparation of T cells, (b) contacting the preparation with cancer cells expressing MR1 protein; (c) isolating a T cell that is specifically reactive to said cancer cells. The invention further relates to a method of preparing a T cell preparation expressing select MR1 recognizing T cell receptors from transgene expression vectors, the use of such T cell preparations in treatment of cancer, and to collections of MR1 reactive T cell receptor encoding nucleic acids and cells.


Find Patent Forward Citations

Loading…